SPACInsider Logo
Healthcare Capital Corp. (HCCC) Adjourns Vote for Alpha Tau Deal Again
by Marlena Haddad on 2022-02-18 at 1:58pm

Healthcare Capital Corp. (NASDAQ:HCCC) announced that it has once again adjourned its special meeting with cancer drug developer Alpha Tau until later today.

The meeting, which was supposed to be held earlier this morning, was convened and then adjourned until 4:00p.m. Eastern Time, this afternon.  HCCC, which adjourned the original meeting on Tuesday, February 15, stated that it still needs additional time to satisfy certain closing conditions.  The SPAC noted on Tuesday that although a sufficient number of stockholders had voted to approve the proposed business combination, not all of the conditions to effect the closing were satisfied.

HCCC is financing the deal with $275 million from its current trust supplemented by a $92 million PIPE at $10 per share. The PIPE drew participation from Yozma, Grand Decade Development, OurCrowd, Medison Group, Regah Ventures and Apax Partners Co-Founders Alan Patricof and Sir Ronald Cohen.

HCCC opened today at $10.20, and spiked to a high of $11.45, but has since dropped to $9.90.

Healthcare Capital originally announced its $650 million deal with Alpha Tau last summer on July 8. Jerusalem-based Alpha Tau is developing unique cancer treatments that utilize alpha radiation to attack tumors with reduced damage to surrounding tissues and cells.


ADVISORS

  • Citigroup is acting as financial advisor to Alpha Tau.
  • Citigroup, Piper Sandler, and Cantor Fitzgerald are acting as joint placement agents on the PIPE.
  • Cantor Fitzgerald is acting as a capital markets advisor to HCC.
  • Value Base M&A Ltd. is also acting as financial advisor on the transaction.
  • Latham & Watkins LLP and Meitar | Law Offices are acting as legal advisors to Alpha Tau.
  • Ellenoff Grossman & Schole LLP and FBC & Co. are acting as legal advisors to HCC.
  • Winston & Strawn LLP is acting as legal advisor to the placement agents.
Recent Posts
by Nicholas Alan Clayton on 2023-06-06 at 7:23am

Priveterra Acquisition Corp. (NASDAQ:PMGM) announced in an 8-K this morning that it plans to adjourn its special meeting to approve its combination with AEON Biopharma from noon today to the same time June 9. The SPAC plans to use this time to further engage with its shareholders as the ballot includes a variety of additional...

by Marlena Haddad on 2023-06-05 at 5:45pm

Latest Non-Redemption Agreements:  EVe Mobility EVe Mobility Acquisition Corp. (EVE) Adds Non-Redemption Agreement On June 5, 2023, EVe Mobility Acquisition Corp. (NYSE:EVE) and the Sponsor entered into non-redemption agreements with unaffiliated third party investors, pursuant to which the Investors have, in connection with the Extension Meeting, agreed not to redeem, or to reverse and revoke any prior...

by Marlena Haddad on 2023-06-05 at 5:44pm

Latest SPAC Liquidations: ST Energy Transition I, MELI Kaszek Pioneer Corp. ST Energy Transition I Ltd. (STET) to Liquidate on June 7 ST Energy Transition I Ltd. (NYSE:STET) announced today that the Board of Directors has elected to dissolve and liquidate the company. Net of taxes and dissolution expenses, the per-share redemption price for the...

by Marlena Haddad on 2023-06-05 at 5:43pm

Worldwide Webb Acquisition Corp. (NASDAQ: WWAC) announced this afternoon that it has secured a $5 million PIPE for its proposed merger with consultancy firm Aeries Technology. While most PIPEs are priced at $10 per share, Worldwide Webb’s $5 million subscription agreement was executed at just $4.48 per share in a private placement to be completed concurrently...

by Marlena Haddad on 2023-06-05 at 5:42pm

Metals Acquisition Corp. (NYSE: MTAL) announced this afternoon that its shareholders have approved its acquisition and business combination with the CSA Copper Mine from Glencore (LON:GLEN) at a special meeting held earlier today. The business combination and merger were overwhelmingly approved as both proposals received 27,538,130 shares in favor of it and just 455,506 shares against it. In...

Privacy Policy|Terms Of Use
Copyright © 2023 SPACInsider, Inc. All Rights Reserved